1. Home
  2. BRBS vs JBIO Comparison

BRBS vs JBIO Comparison

Compare BRBS & JBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRBS
  • JBIO
  • Stock Information
  • Founded
  • BRBS 1893
  • JBIO 2024
  • Country
  • BRBS United States
  • JBIO United States
  • Employees
  • BRBS N/A
  • JBIO N/A
  • Industry
  • BRBS Commercial Banks
  • JBIO
  • Sector
  • BRBS Finance
  • JBIO
  • Exchange
  • BRBS Nasdaq
  • JBIO NYSE
  • Market Cap
  • BRBS 326.4M
  • JBIO 290.1M
  • IPO Year
  • BRBS N/A
  • JBIO N/A
  • Fundamental
  • Price
  • BRBS $3.75
  • JBIO $8.28
  • Analyst Decision
  • BRBS
  • JBIO Strong Buy
  • Analyst Count
  • BRBS 0
  • JBIO 2
  • Target Price
  • BRBS N/A
  • JBIO $15.50
  • AVG Volume (30 Days)
  • BRBS 1.4M
  • JBIO 397.1K
  • Earning Date
  • BRBS 07-23-2025
  • JBIO 08-05-2025
  • Dividend Yield
  • BRBS N/A
  • JBIO N/A
  • EPS Growth
  • BRBS N/A
  • JBIO N/A
  • EPS
  • BRBS N/A
  • JBIO N/A
  • Revenue
  • BRBS $96,787,000.00
  • JBIO N/A
  • Revenue This Year
  • BRBS N/A
  • JBIO N/A
  • Revenue Next Year
  • BRBS N/A
  • JBIO N/A
  • P/E Ratio
  • BRBS N/A
  • JBIO N/A
  • Revenue Growth
  • BRBS 10.08
  • JBIO N/A
  • 52 Week Low
  • BRBS $2.45
  • JBIO $1.61
  • 52 Week High
  • BRBS $4.05
  • JBIO $13.50
  • Technical
  • Relative Strength Index (RSI)
  • BRBS 54.97
  • JBIO N/A
  • Support Level
  • BRBS $3.88
  • JBIO N/A
  • Resistance Level
  • BRBS $3.99
  • JBIO N/A
  • Average True Range (ATR)
  • BRBS 0.11
  • JBIO 0.00
  • MACD
  • BRBS 0.01
  • JBIO 0.00
  • Stochastic Oscillator
  • BRBS 42.31
  • JBIO 0.00

About BRBS Blue Ridge Bankshares Inc.

Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.

About JBIO JADE BIOSCIENCES INC

Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.

Share on Social Networks: